wwwPosted Mar 12th 2008 9:44AM by Paul Foster
Filed under: Amgen Inc (AMGN), Options
Amgen (NASDAQ: AMGN) closed at $44.62 Tuesday.
On 3/13/08, the FDA Oncologic Drugs Advisory Committee (ODAC) is scheduled to review the use of Erythropoiesis stimulation agents, including Aranesp and JNJ's Procrit, to treat chemotherapy induced anemia.
AMGN March option implied volatility is at 51; April is at 41; above its 26-week average of 33 according to Track Data, suggesting larger price movement.
Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com
| # | Blogger | Posts | Cmts |
|---|---|---|---|
| 1 | Joseph Lazzaro | 118 | 0 |
| 2 | Tom Johansmeyer | 105 | 3 |
| 3 | Connie Madon | 54 | 0 |
| 4 | Tom Taulli | 44 | 0 |
| 5 | Steven Mallas | 44 | 0 |
| 6 | Mark Fightmaster | 41 | 0 |
| 7 | Trey Thoelcke | 34 | 0 |
| 8 | Steven Halpern | 30 | 0 |
| 9 | Melly Alazraki | 26 | 0 |
| 10 | Zac Bissonnette | 25 | 0 |
| 11 | Paul Foster | 25 | 0 |
| 12 | Jim Cramer | 22 | 0 |
| 13 | Jon Ogg | 22 | 0 |
| 14 | Brian White | 22 | 0 |
| 15 | Brent Archer | 22 | 0 |
| 16 | Elizabeth Harrow | 18 | 0 |
| 17 | Eric Buscemi | 17 | 0 |
| 18 | Sheldon Liber | 13 | 0 |
| 19 | Michael Fowlkes | 9 | 0 |
| 20 | Beth Gaston Moon | 8 | 0 |
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
Other Weblogs Inc. Network blogs you might be interested in:
Nuclear power is on the comeback trail
Apple backs AT&T in continuing spat with Verizon
Closing Bell: The recession is still over, still... do you feel it?
